スポンサーリンク

Sankyo Biological Reseach Laboratories, Sankyo Co., Ltd. | 論文

• Hemodynamic changes following long-term administration of CS-905, a novel dihydropyridine calcium blocker, in conscious SHR.
• Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker.
• Pharmacological profiles of CS-622, a novel angiotensin converting enzyme inhibitor.
• Beneficial renal effects of CS-905, a novel dihydropyridine calcium blocker, in SHR.

スポンサーリンク